National Institute of Allergy and Infectious Diseases
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

About NIAID
 Who We Are and What We Do
 Organization
  Office of the Director
  DAIDS
  DAIT
  DCR
  DEA
  DIR
  DMID
  VRC
 About the Director
 Working at NIAID
 Finding People
 Visitor Information
 Employee Information


Division of Acquired Immunodeficiency Syndrome (DAIDS)

Overview

The Division of Acquired Immunodeficiency Syndrome (DAIDS) was formed in 1986 to develop and implement the national research agenda to address the HIV/AIDS epidemic. Specifically, the mission of DAIDS is to help ensure an end to the HIV/AIDS epidemic by increasing basic knowledge of the pathogenesis and transmission of the human immunodeficiency virus (HIV), supporting the development of therapies for HIV infection and its complications and co-infections, and supporting the development of vaccines and other prevention strategies. DAIDS accomplishes this through planning, implementing, managing, and evaluating programs through the following research programs and offices:

  1. Basic Sciences Program (BSP) 
  2. Therapeutics Research Program (TRP)
  3. Vaccine Research Program (VRP) 
  4. Prevention Sciences Program (PSP)
  5. Office for Policy in Clinical Research Operations (OPCRO)
  6. Scientific Communications and Information Branch (SCIB)
  7. Scientific Planning and Operations Branch (SPOB)
  8. Office of Clinical Site Oversight (OCSO)

 


Highlights

Dr. Carl Dieffenbach Appointed Director of the NIAID Division of AIDS
Feb. 1, 2008

News Releases

NIAID Media Availability: NIAID Director Fauci Discusses Compelling Scientific Challenges in HIV/AIDS Research
Nov. 3, 2009

Statement of Anthony S. Fauci, M.D., on National Latino AIDS Awareness Day, Oct. 15, 2009
Oct. 15, 2009

National Gay Men’s HIV/AIDS Awareness Day, September 27, 2009
Sept. 25, 2009

HIV Vaccine Regimen Demonstrates Modest Preventive Effect in Thailand Clinical Study
Sept. 24, 2009

Special Announcements

  • Status of NIAID Adenovirus-based Vaccine Studies
  • Considerations for HIV Vaccine Clinical Trials in Adolescents
  • Guidance regarding HIV anti-retroviral treatment in developing countries
  • See Also

    HIV/AIDS



    Highlights

    Dr. Carl Dieffenbach Appointed Director of the NIAID Division of AIDS
    Feb. 1, 2008

    News Releases

    NIAID Media Availability: NIAID Director Fauci Discusses Compelling Scientific Challenges in HIV/AIDS Research
    Nov. 3, 2009

    Statement of Anthony S. Fauci, M.D., on National Latino AIDS Awareness Day, Oct. 15, 2009
    Oct. 15, 2009

    National Gay Men’s HIV/AIDS Awareness Day, September 27, 2009
    Sept. 25, 2009

    HIV Vaccine Regimen Demonstrates Modest Preventive Effect in Thailand Clinical Study
    Sept. 24, 2009

    Special Announcements

  • Status of NIAID Adenovirus-based Vaccine Studies
  • Considerations for HIV Vaccine Clinical Trials in Adolescents
  • Guidance regarding HIV anti-retroviral treatment in developing countries
  • See Also

    HIV/AIDS